MARKET

SCNX

SCNX

Scienture Holdings, Inc
NASDAQ
0.4969
-0.0136
-2.66%
Opening 15:12 03/13 EDT
OPEN
0.5056
PREV CLOSE
0.5105
HIGH
0.5533
LOW
0.4920
VOLUME
2.04M
TURNOVER
--
52 WEEK HIGH
3.170
52 WEEK LOW
0.3720
MARKET CAP
20.19M
P/E (TTM)
-0.2884
1D
5D
1M
3M
1Y
5Y
1D
12 Health Care Stocks Moving In Thursday's Intraday Session
Benzinga · 1d ago
12 Health Care Stocks Moving In Wednesday's After-Market Session
Benzinga · 1d ago
BUZZ-U.S. STOCKS ON THE MOVE-Agricultural stocks, Papa John's, Oil companies
Reuters · 2d ago
12 Health Care Stocks Moving In Wednesday's Intraday Session
Benzinga · 2d ago
Morning News Wrap-Up 3/11/26: Wednesday’s Biggest Stock Market Stories!
TipRanks · 2d ago
Scienture Holdings Stock Climbs 31% After GPO Agreements For REZENOPY Naloxone Spray
NASDAQ · 2d ago
Why Is Scienture Holdings Stock (SCNX) Up Today?
TipRanks · 2d ago
BUZZ-Scienture rises after deals to expand reach of opioid overdose spray
Reuters · 2d ago
More
About SCNX
Scienture Holdings, Inc., through its wholly owned subsidiary, Scienture, LLC, is a specialty pharmaceutical company focused on providing enhanced value to patients, physicians and caregivers by offering specialty products to satisfy unmet market needs. Scienture, LLC is focused on developing and commercializing products for the treatment of central nervous system and cardiovascular diseases. Scienture LLC is developing a range of product candidates, including new potential treatments for hypertension, migraine, pain and thrombosis and other related disorders. The Company's product candidates include SCN- 102 (hypertension), SCN- 104 (CNS-Pain), SCN- 106 (Cardiovascular) and SCN- 107 (Pain). SCN-102 is an oral liquid formulation of losartan potassium in development for the treatment of hypertension. SCN-104 is a multi-dose pen-based delivery system for self-injection and increased patient convenience, which is in development for the acute treatment of migraine headaches.

Webull offers Scienture Holdings Inc stock information, including NASDAQ: SCNX real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, SCNX stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading SCNX stock methods without spending real money on the virtual paper trading platform.